News

Latest draft work programme of cluster 5: climate, energy and mobility now available

Published on | 4 years ago

Programmes Energy Transport Climate/Environment

The launch of the full Horizon Europe programme is now very close.

Here you can find the latest version of the work programme for cluster 5 climate, energy and mobility.

This is still a draft version so minor changes to the texts are still possible.

If you want information regarding the background of these calls you can contact the PC representatives lut.bollen@vlaanderen.be (energy/climate) and hilde.vermeulen@vlaanderen.be (mobility)

You can also email the NCP’s bart.decaesemaeker@vlaio.be and pascal.verheye@vlaio.be  if you would like to receive more information on the NCP services regarding Horizon Europe.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1646 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.